Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids
Clinical Lung and Allergy Research, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine, Karolinska University Hospital, Stockholm, Sweden; The Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine, Karolinska University Hospital, Stockholm, Sweden; The Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden; Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine, Karolinska University Hospital, Stockholm, Sweden; The Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden; Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden; Laboratoire AntiDopage Français, Université Paris-Saclay, Châtenay-Malabry, France.
Visa övriga samt affilieringar
2023 (Engelska)Ingår i: ERJ Open Research, E-ISSN 2312-0541, Vol. 9, nr 5, artikel-id 00269-2023Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Rationale: Patients with severe asthma are dependent upon treatment with high doses of inhaled corticosteroids (ICS) and often also oral corticosteroids (OCS). The extent of endogenous androgenic anabolic steroid (EAAS) suppression in asthma has not previously been described in detail. The objective of the present study was to measure urinary concentrations of EAAS in relation to exogenous corticosteroid exposure.

Methods: Urine collected at baseline in the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcomes) study of severe adult asthmatics (SA, n=408) was analysed by quantitative mass spectrometry. Data were compared to that of mild-to-moderate asthmatics (MMA, n=70) and healthy subjects (HC, n=98) from the same study.

Measurements and main results: The concentrations of urinary endogenous steroid metabolites were substantially lower in SA than in MMA or HC. These differences were more pronounced in SA patients with detectable urinary OCS metabolites. Their dehydroepiandrosterone sulfate (DHEA-S) concentrations were <5% of those in HC, and cortisol concentrations were below the detection limit in 75% of females and 82% of males. The concentrations of EAAS in OCS-positive patients, as well as patients on high-dose ICS only, were more suppressed in females than males (p<0.05). Low levels of DHEA were associated with features of more severe disease and were more prevalent in females (p<0.05). The association between low EAAS and corticosteroid treatment was replicated in 289 of the SA patients at follow-up after 12–18 months.

Conclusion: The pronounced suppression of endogenous anabolic androgens in females might contribute to sex differences regarding the prevalence of severe asthma.

Ort, förlag, år, upplaga, sidor
European Respiratory Society, 2023. Vol. 9, nr 5, artikel-id 00269-2023
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
URN: urn:nbn:se:umu:diva-215705DOI: 10.1183/23120541.00269-2023ISI: 001075451800015PubMedID: 37868143Scopus ID: 2-s2.0-85173750900OAI: oai:DiVA.org:umu-215705DiVA, id: diva2:1811585
Forskningsfinansiär
Hjärt-Lungfonden, HLF 20210519VetenskapsrådetEU, FP7, Sjunde ramprogrammetKonsul Berghs StiftelseKarolinska InstitutetVårdalstiftelsenTillgänglig från: 2023-11-13 Skapad: 2023-11-13 Senast uppdaterad: 2023-11-13Bibliografiskt granskad

Open Access i DiVA

fulltext(1173 kB)37 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1173 kBChecksumma SHA-512
76deb426f3b15d3af1bac12234604d4c7c2e77f68f1aded0c6c5db0be920ca9e4127e19ae073d3e21307f465679311a090ba6e7db93706fe6e7c12d8140fabe8
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Behndig, Annelie F.

Sök vidare i DiVA

Av författaren/redaktören
Behndig, Annelie F.
Av organisationen
Institutionen för folkhälsa och klinisk medicin
I samma tidskrift
ERJ Open Research
Lungmedicin och allergi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 37 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 226 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf